Company Molecular Medicine Supply Srl with Fiscal Code 30379330
recorded a turnover of 2024 of
- ,
with a net profit of
-1.075
and having an average number of employees of
1.
The company operates in the field of Fabricarea preparatelor farmaceutice having the NACE code 2120.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Molecular Medicine Supply Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
299.785
240.112
232.125
231.811
178.117
0
5.054
0
0
0
Total Income - EUR
313.098
254.137
237.488
322.543
578.822
0
5.054
0
0
0
Total Expenses - EUR
244.175
236.423
212.765
260.274
447.252
7.853
611
954
952
1.075
Gross Profit/Loss - EUR
68.923
17.714
24.723
62.270
131.569
-7.852
4.443
-954
-952
-1.075
Net Profit/Loss - EUR
62.238
12.586
13.644
59.058
125.781
-7.852
4.292
-954
-952
-1.075
Employees
1
1
1
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Check the financial reports for the company - Molecular Medicine Supply Srl
Financial Rating - MOLECULAR MEDICINE SUPPLY SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Molecular Medicine Supply Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Molecular Medicine Supply Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Molecular Medicine Supply Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Molecular Medicine Supply Srl - CUI 30379330
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
916.873
774.899
598.135
398.477
0
129
4.950
4.934
4.890
4.863
Current Assets
233.504
198.775
180.771
41.329
438.005
1.138
2.182
1.616
712
562
Inventories
0
17
0
0
0
0
0
0
0
0
Receivables
232.508
198.122
179.442
40.696
383.010
957
515
519
521
520
Cash
996
636
1.329
633
54.995
181
1.667
1.097
191
42
Shareholders Funds
29.092
13.121
14.169
59.574
184.201
-5.289
-880
-1.837
-2.783
-3.843
Social Capital
450
445
438
430
421
413
404
406
404
402
Debts
1.121.285
960.553
764.737
380.232
253.804
6.556
8.012
8.387
8.385
9.268
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"2120 - 2120"
CAEN Financial Year
2120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
562 euro in 2024 which includes Inventories of
0 euro, Receivables of
520 euro and cash availability of
42 euro.
The company's Equity was valued at
-3.843 euro, while total Liabilities amounted to
9.268 euro.
Equity decreased by -1.075 euro, from -2.783 euro in 2023, to -3.843 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Molecular Medicine Supply Srl